Stock listing

LPCN Stock Price, News, Filings & Events — Lipocine Inc.

Selected listing: LPCN · BOATS · USD · US

This page tracks Lipocine Inc.'s LPCN:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LPCN:BOATS. LPCN:BOATS is the stock-level entry point for investors researching Lipocine Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lipocine Inc. is a public company traded under the ticker LPCN in the American market. With a market capitalization of approximately $17.1 million, Lipocine focuses on developing innovative therapies for various medical conditions. The company is committed to advancing its product pipeline to address unmet medical needs.

LPCN:BOATSUSDUSUpdated September 11, 2026
Lipocine Inc. logo
Ticker
LPCN:BOATS
Asset type
Stock
Market cap
$18.7M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Lipocine Inc. LPCN:BOATS stock context

This page tracks Lipocine Inc.'s LPCN:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LPCN:BOATS. LPCN:BOATS is the stock-level entry point for investors researching Lipocine Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lipocine Inc. is a public company traded under the ticker LPCN in the American market. With a market capitalization of approximately $17.1 million, Lipocine focuses on developing innovative therapies for various medical conditions. The company is committed to advancing its product pipeline to address unmet medical needs.

Latest news from Lipocine Inc.

All Lipocine Inc. news →

Research Lipocine Inc.

Alternate listings